SCHEMBL7534714

SCHEMBL7534714

CC(C)(C)OC(=O)CC(=O)OC(C)(C)C.O=C(O)C(C(=O)O)c1cc(F)c([N+](=O)[O-])c(OCc2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.40
CTSV O60911 2/20 0.40
CTSL P07711 2/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
ITGA4 P13612 1/20 0.38
ITGB7 P26010 1/20 0.38
ALDH1A1 P00352 2/20 0.37
HTT P42858 2/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 1/20 0.36
PPIA P62937 1/20 0.36
MYC P01106 1/20 0.35
MAX P61244 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
MGMT P16455 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7430770 0.88 CYP19A1 (0.42) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL6594485 0.85 MTNR1A (0.39) MAPTALDH1A1HTTLMNA
SCHEMBL2434981 0.84 ITGA4 (0.39) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL31321850 0.73 LMNA (0.53) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL31667350 0.72 CYP19A1 (0.52) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL2434879 0.72 CYP19A1 (0.51) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL2432543 0.71 CYP19A1 (0.44) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL6373720 0.70 MYC (0.50) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL6373712 0.70 MYC (0.50) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL22412563 0.70 KDM1A (0.52) CYP19A1CTSVCTSLMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133484-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS AstraZeneca AB (SE) 2001-09-19 EP disclosed
WO-2000005223-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS ASTRAZENECA AB (SE) 2000-02-03 WO disclosed